주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Conference speaker

Alan DT Barrett

ADB

Alan DT Barrett

Director, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, USA

Alan DT Barrett, Ph.D., D.Sc (Hon) is Director of the Sealy Institute for Vaccine Sciences, Professor in the Department of Pathology, and is holder of the John Sealy Distinguished University Chair in Vaccinology at the University of Texas Medical Branch at Galveston. He obtained his PhD from the University of Warwick, completed a postdoctoral fellowship at the London School of Hygiene and Tropical Medicine, and became an academic at the University of Surrey (1985-1993). In 1993. Dr. Barrett moved to the University of Texas Medical Branch and became Director of the Sealy Center for Vaccine Development (2008), which was re-designated the Sealy Institute for Vaccine Sciences in 2017. He was elected Fellow of the International Society for Vaccines (2014), Fellow of the American Academy of Microbiology (2016), and was awarded an honorary Doctor of Science Degree from the University of Warwick (2018). His research interests are vaccine development of flaviviruses (dengue, Japanese encephalitis, West Nile, tick-borne encephalitis, yellow fever, and Zika). His research has resulted in him authoring more than 375 papers, reviews, commentaries, and book chapters. He has served on many World Health Organization committees, has been a member of multiple working groups of the CDC Advisory Committee on Immunization Practices, and was Co-Chair for a breakout group evaluating the Flaviviridae Family, NIH Workshop on Pandemic Preparedness. He is currently a member of the Vaccine Research, Development and Manufacturing Committee of the Coalition for Epidemic Preparedness Innovations. He is Founding Editor-in-Chief of Nature partner journal (npj) Vaccines (2015-present).